CD4 and systemic lupus erythematosus: The mechanism underlying the amelioration of SLE disease after NKG2D antibody treatment might involve blockade of the interaction between NKG2D+CD4+ T cells and Treg cells, thereby causing restoration of the Treg frequency as observed in treated mice.